Healthcare Services Acquisition Corporation Warrant
HCARW
HCARW was delisted on the 22nd of December, 2022.
0 hedge funds and large institutions have $0 invested in Healthcare Services Acquisition Corporation Warrant in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 47 closing their positions.
100% less funds holding
Funds holding: 47 → 0 (-47)
100% less capital invested
Capital invested by funds: $2.25M → $0 (-$2.25M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 47
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
-$1.24M |
| 2 |
SCM
Segantii Capital Management
Hong Kong
|
-$745K |
| 3 |
BlackRock
New York
|
-$32K |
| 4 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$22K |
| 5 |
CCA
Castle Creek Arbitrage
Avon,
Colorado
|
-$22K |
HCARW Hedge Fund Activity: Q4 2022 in Review
0 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Healthcare Services Acquisition Corporation Warrant (HCARW) for Q4 2022, worth a combined $0 — down 100% from $2.25M a quarter earlier.
Sellers outnumbered buyers: 47 funds closed out of HCARW and 0 opened new positions — a net loss of 47 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Radcliffe Capital Management, exiting entirely with an estimated $1.24M sold.
- 0 institutional investors held Healthcare Services Acquisition Corporation Warrant (HCARW) as of Q4 2022, down from 47 in Q3 2022.
- Funds reported $0 of Healthcare Services Acquisition Corporation Warrant stock for Q4 2022, down 100% quarter-over-quarter.
- 0 funds opened new Healthcare Services Acquisition Corporation Warrant positions in Q4 2022 and 47 closed out, a net change of -47 holders.
- The largest Healthcare Services Acquisition Corporation Warrant seller in Q4 2022 was Radcliffe Capital Management, an estimated $1.24M sold.
Based on aggregated 13F filings for Q4 2022.